Chaim Hurvitz - Aug 30, 2023 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Chaim Hurvitz
Stock symbol
NRXP
Transactions as of
Aug 30, 2023
Transactions value $
$20,125
Form type
4
Date filed
9/11/2023, 09:15 AM
Previous filing
Sep 27, 2023
Next filing
Jun 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock, par value $0.001 per share Purchase $20.1K +70K +14% $0.29 570K Aug 30, 2023 Direct F1
holding NRXP Common Stock, par value $0.001 per share 1.44M Aug 30, 2023 By Shirat HaChaim Ltd. F2
holding NRXP Common Stock, par value $0.001 per share 208K Aug 30, 2023 By CH Health-Private Venture Capital Ltd. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.
F2 Chaim Hurwitz is the owner of Shirat HaChaim Ltd.
F3 Chaim Hurwitz is the owner of CH Health-Private Venture Capital Ltd.